Prostate Cancer Surgery and Oncological Care
Clinical research in prostate cancer at Canisius Wilhelmina Ziekenhuis focuses on outcomes after radical prostatectomy, with attention to both functional recovery and oncological results in men undergoing treatment for localized disease.
- Radical prostatectomy
- Oncological outcomes
- Functional recovery
The hospital’s work in this area links surgical care with patient-centered endpoints relevant to quality of life and disease control.
Testosterone Deficiency and Late-onset Hypogonadism
Another area of interest is testosterone deficiency in men with late-onset hypogonadism, particularly where hormonal symptoms intersect with prostate cancer treatment and postoperative sexual health.
- Testosterone replacement therapy
- Sexual functioning
- Hormonal symptoms
This research domain reflects a focus on endocrine and urological issues that affect men’s health during cancer care.
PSMA PET/CT in Primary Staging
The sponsor is also involved in imaging-based research using PSMA PET/CT for the primary staging of prostate cancer, with interest in improving selection for nodal surgery and refining preoperative assessment.
- PSMA PET/CT imaging
- Primary staging
- Pelvic lymph node assessment
This area supports more targeted use of diagnostic imaging in surgical planning for newly diagnosed patients.
Pelvic Lymph Node Dissection and Surgical Burden
Research activity also addresses extended pelvic lymph node dissection, including its role in staging, procedure selection, and the balance between diagnostic value and treatment-related burden.
- Extended pelvic lymph node dissection
- Surgical morbidity
- Healthcare cost
These studies are centered on reducing unnecessary intervention while maintaining appropriate cancer management.
